Clinical Trials Logo
  1. Home
  2. Inflammatory Disease
  3. NCT05857215

A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

Inflammatory Disease Clinical Trial

Official title:
A Phase 1, Double-blind, Single and Multiple-Dose Study of Safety, Tolerability and Pharmacokinetics of Amilo-5MER in Healthy Volunteers

Clinical Trial Summary

This is a three-part, single Centre, double-blind, randomized, placebo-controlled first-in-human study of single ascending doses (SADs, Part 1) and multiple doses (Part 2) of amilo-5MER in healthy young adult male subjects and a single dose cohort in healthy elderly male and female subjects (Part 3)

Clinical Trial Description

This is a three-part, single Centre, double-blind, randomized, placebo-controlled first-in-human study of single ascending doses (SADs, Part 1) and multiple doses (Part 2) of amilo-5MER in healthy young adult male subjects and a single dose cohort in healthy elderly male and female subjects (Part 3). The study aim is to assess and characterize the safety and tolerability of single and multiple doses of amilo-5MER in healthy young adult subjects and single doses in healthy elderly subjects. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05857215
Study type Interventional
Source Galmed Pharmaceuticals Ltd
Contact
Status Completed
Phase Phase 1
Start date March 5, 2021
Completion date July 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03964324 - NO Measurements in Screening for Asthma and OSA, in Patients With Severe Snoring N/A
Recruiting NCT03963648 - NO Measurements in Screening for Asthma and OSA, in Patients With CRSwNP N/A
Not yet recruiting NCT04997343 - Neurophysiological Assessment in Patients With Multiple Sclerosis N/A
Completed NCT01695876 - A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects Phase 1
Not yet recruiting NCT05546788 - Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis Phase 1
Recruiting NCT03651518 - Personalized Therapies in Inflammatory Complex Disease Phase 2
Not yet recruiting NCT05544448 - In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases N/A
Completed NCT02552004 - Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study N/A
Completed NCT04368494 - Exercise Therapy in Patients With Axial Spondyloarthritis N/A
Completed NCT03878134 - Translational Development of Photon-counting CT Imaging N/A
Recruiting NCT06059989 - inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease Phase 3
Completed NCT02959138 - Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Phase 1
Recruiting NCT04565821 - Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe N/A
Recruiting NCT05509075 - Nutraceuticals and Functional Foods
Active, not recruiting NCT05944822 - Pro-inflammatory Cytokines in Case of Essure®
Completed NCT05115370 - Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19
Active, not recruiting NCT03604406 - The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept Phase 2
Completed NCT05022017 - Description of Statics by EOS Imaging and Evaluation of the Efficacy of Intradiscal Corticosteroid Infiltration
Recruiting NCT05364294 - Molecular Diagnosis of Systemic Autoinflammatory Diseases
Recruiting NCT05860400 - Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study